RADIQAL Study (Radiation Dose and Image Quality Trial)

NARecruitingINTERVENTIONAL
Enrollment

824

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Coronary Artery Disease
Interventions
DEVICE

treatment with the Azurion system with Xres5

treatment with the Azurion system with Xres5

OTHER

Azurion with Clairy IQ

Azurion system with the standard of care (ClarityIQ/Xres4)

Trial Locations (6)

30322

NOT_YET_RECRUITING

Emory University Hospital, Atlanta

80045

NOT_YET_RECRUITING

NYP Columbia, New York

80204

NOT_YET_RECRUITING

University of Colorado, Denver

Unknown

RECRUITING

University Hospital Královské Vinohrady, Prague

RECRUITING

Aarhus university hospital, Aarhus

RECRUITING

Hospital Clinico San Carlos, Madrid

All Listed Sponsors
lead

Philips Clinical & Medical Affairs Global

INDUSTRY